I have just taken over the role as President and CEO of Hitachi Medical Corporation from Kiyoshi Hamamatsu. The economy in Japan continues to be uncertain due to flagging corporate profits caused by the global downturn in the economy and the continued rise in the value of the yen. I truly appreciate the opportunity to lead the company although it will be a huge challenge under such circumstances.

Hitachi Medical Corporation has been continuously developing as the manufacturer of the Hitachi Group for diagnostic imaging systems by providing our customers with state-of-the-art products while leading the market. Based on the corporate concept ”to contribute to the advancement of health care and contribute to the health of people in the whole world through provision of better medical systems”, we have taken on all that are involved in medical imaging diagnostic equipment and medical information systems from their development, manufacture, quality assurance, sales, to installation and maintenance services. We consider that covering from upstream for the development to downstream for maintenance services is extremely important for providing our customers from all over the world with tailor-made products. We are determined to work as a team in the whole group in Japan and overseas to provide you with products that are reliable.
Furthermore, Hitachi Group will enforce social innovational businesses globally to contribute to social development of each country such as innovating the social system in developed countries and constructing infrastructure in developing countries. Hitachi Medical Corporation will play a role in this project through medical businesses.

Mr. Hamamatsu had worked hard to strengthen our business foundation since 2008 by reinforcing power for product development, sales power and business quality. I will succeed and develop these measures to accelerate further business expansion.
We will continue to provide high quality products that are truly useful for the clinical front not only in Japan but also in the US, Europe, China and other Asian countries based on the corporate concept “to contribute to the advancement of health care and contribute to the health of people in the whole world through provision of better medical systems” to continuously evolve as a company.
Moreover, we will devote even more efforts in programs related to the CSR (Corporate Social Responsibility) such as compliance, environmental preservation and social contribution under corporate activities complying with "Basics and Right Path".